Skip to main content
J

Jinhe Biotechnology CO.,LTD. — Investor Relations & Filings

Ticker · 002688 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,825 across all filing types
Latest filing 2025-10-14 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002688

About Jinhe Biotechnology CO.,LTD.

https://www.jinhe.com.cn

Jinhe Biotechnology CO.,LTD. specializes in the research, development, and manufacturing of animal health products and feed additives. The company is a prominent global producer of chlortetracycline (CTC), maintaining extensive production capacity for feed-grade antibiotics. Its diverse product portfolio includes veterinary pharmaceuticals such as salinomycin and monensin, alongside a range of biological products and animal vaccines. Jinhe Biotechnology leverages advanced fermentation technology and integrated research capabilities to provide solutions for the livestock and poultry sectors. The company focuses on improving animal growth performance and disease prevention through standardized production processes and a global distribution network. Its operations span the development of specialized additives and the provision of comprehensive veterinary medical products designed to support large-scale animal husbandry.

Recent filings

Filing Released Lang Actions
委托理财管理制度
Regulatory Filings
2025-10-14 Chinese
防范控股股东或实际控制人及关联方资金占用管理办法
Regulatory Filings
2025-10-14 Chinese
未来三年(2025-2027年度)股东分红回报规划
Regulatory Filings
2025-10-14 Chinese
关于2025年度以简易程序向特定对象发行股票预案披露的提示性公告
Regulatory Filings
2025-10-14 Chinese
金河生物科技股份有限公司2025年度以简易程序向特定对象发行A股股票募集资金使用的可行性分析报告
Regulatory Filings
2025-10-14 Chinese
董事会审计委员会议事规则
Regulatory Filings
2025-10-14 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.